Toolkit/stapled peptides

stapled peptides

Construct Pattern·Research·Since 2020

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads

Usefulness & Problems

Why this is useful

Stapled peptides are presented as engineered peptide modalities used to inhibit protein-protein interactions. The review frames them as a mature enough approach to generate therapeutic leads.; inhibiting protein-protein interactions; generating therapeutic leads

Source:

Stapled peptides are presented as engineered peptide modalities used to inhibit protein-protein interactions. The review frames them as a mature enough approach to generate therapeutic leads.

Source:

inhibiting protein-protein interactions

Source:

generating therapeutic leads

Problem solved

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.; providing peptide-based inhibitors for protein-protein interactions; improving pharmacological profiles of peptide leads

Source:

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.

Source:

providing peptide-based inhibitors for protein-protein interactions

Source:

improving pharmacological profiles of peptide leads

Problem links

improving pharmacological profiles of peptide leads

Literature

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.

Source:

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.

providing peptide-based inhibitors for protein-protein interactions

Literature

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.

Source:

They are used to target protein-protein interactions and to improve properties relevant to pharmacological performance.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

No target processes tagged yet.

Input: Chemical

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator

The abstract indicates that successful use depends on construction methods, design methodologies, and structural analysis of peptide-target complexes.; requires design methodology for construction

The abstract does not specify which protein-protein interaction classes remain difficult or where stapled peptides fail.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1clinical translationsupports2020Source 1needs review

A number of stapled peptide drug candidates had recently entered clinical trials by 2020.

A number of stapled peptide drug candidates have recently entered clinical trials.
Claim 2design considerationsupports2020Source 1needs review

Properties contributing to improved pharmacological profiles are an important consideration in stapled peptide design.

discuss properties that contribute towards improved pharmacological profiles
Claim 3maturity or readinesssupports2020Source 1needs review

Stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads.

stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads

Approval Evidence

1 source3 linked approval claimsfirst-pass slug stapled-peptides
stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads

Source:

clinical translationsupports

A number of stapled peptide drug candidates had recently entered clinical trials by 2020.

A number of stapled peptide drug candidates have recently entered clinical trials.

Source:

design considerationsupports

Properties contributing to improved pharmacological profiles are an important consideration in stapled peptide design.

discuss properties that contribute towards improved pharmacological profiles

Source:

maturity or readinesssupports

Stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads.

stapled peptide methodologies have evolved to a point where they can be used with confidence to generate therapeutic leads

Source:

Comparisons

Source-stated alternatives

The abstract does not explicitly name alternative inhibitor modalities.

Source:

The abstract does not explicitly name alternative inhibitor modalities.

Source-backed strengths

can be used with confidence to generate therapeutic leads; some drug candidates have entered clinical trials

Source:

can be used with confidence to generate therapeutic leads

Source:

some drug candidates have entered clinical trials

Compared with bacterial degrons

stapled peptides and bacterial degrons address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

stapled peptides and Pyr-NHS-functionalised 3D graphene foam electrode biosensor address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

Compared with rM3Ds

stapled peptides and rM3Ds address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

Ranked Citations

  1. 1.
    StructuralSource 1Peptide Science2020Claim 1Claim 2Claim 3

    Extracted from this source document.